X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (153) 153
index medicus (148) 148
humans (140) 140
male (134) 134
female (127) 127
aged (123) 123
middle aged (121) 121
adult (88) 88
chemotherapy (84) 84
lung neoplasms - drug therapy (74) 74
lung neoplasms - pathology (62) 62
carcinoma, non-small-cell lung - drug therapy (60) 60
aged, 80 and over (59) 59
cancer (54) 54
lung cancer (49) 49
lung cancer, non-small cell (48) 48
treatment outcome (48) 48
retrospective studies (45) 45
carcinoma, non-small-cell lung - pathology (43) 43
non-small cell lung cancer (39) 39
medicine & public health (37) 37
prognosis (37) 37
analysis (36) 36
gefitinib (36) 36
care and treatment (35) 35
lung neoplasms - mortality (34) 34
respiratory system (34) 34
disease-free survival (32) 32
neoplasm staging (31) 31
antineoplastic agents - therapeutic use (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (28) 28
mutation (28) 28
carcinoma, non-small-cell lung - mortality (25) 25
pulmonary/respiratory (25) 25
cancer research (24) 24
lung neoplasms - genetics (24) 24
tumors (24) 24
survival (23) 23
cisplatin (22) 22
epidermal growth factor (21) 21
pharmacology & pharmacy (21) 21
japan (20) 20
metastasis (20) 20
patients (20) 20
trial (20) 20
hematology, oncology and palliative medicine (19) 19
kaplan-meier estimate (19) 19
lung cancer, small cell (19) 19
research (19) 19
adenocarcinoma (18) 18
radiotherapy (18) 18
cell lung-cancer (17) 17
pharmacology/toxicology (17) 17
therapy (17) 17
carcinoma, non-small-cell lung - genetics (16) 16
lung neoplasms - metabolism (16) 16
non-small-cell lung cancer (16) 16
nsclc (16) 16
protein kinase inhibitors - therapeutic use (16) 16
survival rate (16) 16
disease progression (15) 15
docetaxel (15) 15
tyrosine (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
carboplatin (14) 14
receptor, epidermal growth factor - genetics (14) 14
survival analysis (14) 14
angiogenesis (13) 13
antineoplastic agents - administration & dosage (13) 13
antineoplastic agents - adverse effects (13) 13
erlotinib (13) 13
internal medicine (13) 13
original (13) 13
pathology (13) 13
quinazolines - therapeutic use (13) 13
carcinoma (12) 12
carcinoma, non-small-cell lung - metabolism (12) 12
diagnosis (12) 12
immunohistochemistry (12) 12
phase-iii (12) 12
phase-iii trial (12) 12
solid tumors (12) 12
time factors (12) 12
usage (12) 12
cancer therapies (11) 11
cisplatin - administration & dosage (11) 11
expression (11) 11
hypoxia (11) 11
lung neoplasms - surgery (11) 11
medical research (11) 11
receptor, epidermal growth factor - antagonists & inhibitors (11) 11
young adult (11) 11
adjuvant chemotherapy (10) 10
biopsy (10) 10
combination (10) 10
diagnostic radiology (10) 10
dose-response relationship, drug (10) 10
drug administration schedule (10) 10
egfr (10) 10
egfr mutation (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Respiratory Medicine, The, ISSN 2213-2600, 2016, Volume 5, Issue 1, pp. 42 - 50
Journal Article
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1001 - 1005
Although third‐generation epidermal growth factor receptor‐tyrosine kinase inhibitors ( EGFR ‐ TKI ) can overcome T790M‐mediated resistance in non‐small‐cell... 
epidermal growth factor receptor‐tyrosine kinase inhibitors | non‐small‐cell lung cancer | rebiopsy | Disease progression | T790M mutation | Non-small-cell lung cancer | Rebiopsy | Epidermal growth factor receptor-tyrosine kinase inhibitors | epidermal growth factor receptor-tyrosine kinase inhibitors | non-small-cell lung cancer | GEFITINIB | NSCLC-PATIENTS | BIOPSY | ACQUIRED-RESISTANCE | EGFR MUTATION | CHEMOTHERAPY | ROCILETINIB | TKI | ONCOLOGY | AZD9291 | Biopsy - methods | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | DNA Mutational Analysis | Treatment Failure | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Japan | Biopsy - statistics & numerical data | Disease Progression | Drug Resistance, Neoplasm - genetics | Neoplasm Metastasis - pathology | Protein Kinase Inhibitors - therapeutic use | Neoplasm Metastasis - diagnosis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Clinical Trials as Topic - methods | Mutation | Drug Resistance, Neoplasm - drug effects | Tyrosine | Medical research | Care and treatment | Epidermal growth factor | Analysis | Medicine, Experimental | Phenols | Development and progression | Lung cancer, Non-small cell | Index Medicus | Original
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 6/2015, Volume 23, Issue 6, pp. 1699 - 1708
Journal Article
Nutrition and Cancer, ISSN 0163-5581, 07/2019, Volume 71, Issue 5, pp. 767 - 771
This study aimed to explore the tolerability and safety of platinum combination chemotherapy in malnourished patients with advanced non-small cell lung cancer... 
PHASE-III TRIAL | PROGNOSTIC SCORE GPS | NUTRITION & DIETETICS | ONCOLOGY | STATUS ECOG | COOPERATIVE-ONCOLOGY-GROUP | Chemotherapy | Hematology | Toxicity | Platinum | Lung cancer | Non-small cell lung carcinoma | Malnutrition | Survival | Nutritional status
Journal Article
Journal Article
BMC CANCER, ISSN 1471-2407, 08/2019, Volume 19, Issue 1, pp. 762 - 762
Background Acquired immunodeficiency associated with thymoma is a rare disorder. Here we reported a case of acquired immunodeficiency with thymoma, with an... 
Meningitis | Thymoma | ONCOLOGY | Radiotherapy | Good syndrome | Immunodeficiency | Case studies | Complications and side effects | Listeriosis | Development and progression | Diagnosis | Index Medicus
Journal Article
Cancer Science, ISSN 1347-9032, 06/2014, Volume 105, Issue 6, pp. 683 - 689
Epidermal growth factor receptor‐tyrosine kinase inhibitors ( EGFR ‐ TK I) are effective for non‐small cell lung cancers ( NSCLC ) with EGFR ‐activating... 
peroxisome proliferator‐activated receptor gamma | motility | Efatutazone | epidermal growth factor receptor‐tyrosine kinase inhibitor resistance | non‐small cell lung cancer | Peroxisome proliferator-activated receptor gamma | Epidermal growth factor receptor-tyrosine kinase inhibitor resistance | Motility | Non-small cell lung cancer | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Humans | Lung Neoplasms - metabolism | Drug Resistance, Neoplasm | Lung Neoplasms - pathology | Antineoplastic Agents - pharmacology | Thiazolidinediones - pharmacology | Wound Healing - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Epidermal Growth Factor - genetics | Down-Regulation | Carcinoma, Non-Small-Cell Lung - metabolism | Smad2 Protein - metabolism | Phosphatidylinositol 3-Kinases - genetics | Cell Movement - drug effects | PPAR gamma - antagonists & inhibitors | Cell Differentiation - drug effects | Transforming Growth Factor beta2 - antagonists & inhibitors | PPAR gamma - agonists | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Enzyme Activation - genetics | Quinazolines - pharmacology | Index Medicus | non-small cell lung cancer | Original | epidermal growth factor receptor-tyrosine kinase inhibitor resistance | peroxisome proliferator-activated receptor gamma
Journal Article
Investigational new drugs, ISSN 0167-6997, 06/2019, pp. 1 - 8
3rd-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), including osimertinib, have reasonable efficacy in non-small-cell lung... 
Tyrosine | Effectiveness | Effusion | Epidermal growth factor receptors | Medical treatment | Lung cancer | Non-small cell lung carcinoma | Cerebrospinal fluid | Kinases | Confidence intervals | Epidermal growth factor | Mutation | Protein-tyrosine kinase | Growth factors
Journal Article